(Q51600357)

English

Lovastatin does not affect oral glucose tolerance in hypercholesterolemic patients.

scientific article published in June 1993

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8366184

Lovastatin does not affect oral glucose tolerance in hypercholesterolemic patients. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8366184

hypercholesterolemia

0 references

author name string

McCrea JB

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8366184

Fruncillo RJ

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8366184

Holland SD

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8366184

Conroy JA

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8366184

Shingo S

5

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8366184

Spector R

6

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8366184

Bjornsson TD

7

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8366184

publication date

1 June 1993

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8366184

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8366184

33

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8366184

6

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8366184

581-585

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8366184

Diabetes as an atherogenic factor.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04707.X

21 January 2018

Comparison of the effects of lovastatin and gemfibrozil on lipids and glucose control in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04707.X

21 January 2018

Effects of lovastatin in diabetic patients treated with chlorpropamide

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04707.X

21 January 2018

Identifiers

10.1002/J.1552-4604.1993.TB04707.X

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8366184

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8366184

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51600357&oldid=943534209"